Patient Perception of Negative Noninvasive Prenatal Testing Results

AJP Reports

Volumn 6, Issue 4, 2016, Pages e391-e406

  Wittman, A Theresa ^a,b   Hashmi, S Shahrukh ^a,c   Mendez Figueroa, Hector ^c   Nassef, Salma ^b   Stevens, Blair ^a,c   Singletary, Claire N ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

genetic counseling; limitations of prenatal screening; negative noninvasive prenatal testing; noninvasive prenatal testing; patient perception of negative screening; prenatal screening; prenatal screening for aneuploidy

Indexed keywords

ADULT; AGE; ANEUPLOIDY; ARTICLE; COHORT ANALYSIS; DOWN SYNDROME; EDUCATION; ETHNICITY; FEMALE; GENETIC COUNSELING; HEALTH SURVEY; HUMAN; INCOME; INTELLECTUAL IMPAIRMENT; MAJOR CLINICAL STUDY; MATERNAL AGE; NON INVASIVE PROCEDURE; PATIENT ATTITUDE; PATIENT WORRY; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEX CHROMOSOME ABERRATION; TRISOMY 13; TRISOMY 18; YOUNG ADULT;

EID: 85032866603     PISSN: 21576998     EISSN: 21577005     Source Type: Journal    
DOI: 10.1055/s-0036-1594243     Document Type: Article

References (18)

1. Driscoll D. A., Gross S. Clinical practice. Prenatal screening for aneuploidy. N Engl J Med: 2009; 360 24 2556 2562
2. Wapner R., Thom E., Simpson J. L., et al. First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med: 2003; 349 15 1405 1413
3. Positive predictive value again. BJOG: 1999; 106 9 vii viii
4. Palomaki G. E., Kloza E. M., Lambert-Messerlian G. M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med: 2011; 13 11 913 920
5. Palomaki G. E., Deciu C., Kloza E. M., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med: 2012; 14 3 296 305
6. Bianchi D. W., Platt L. D., Goldberg J. D., Abuhamad A. Z., Sehnert A. J., Rava R. P.; MatErnal BLood IS Source to Accurately diagnose fetal aneuploidy (MELISSA) Study Group. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol: 2012; 119 5 890 901
7. Gil M. M., Quezada M. S., Bregant B., Ferraro M., Nicolaides K. H. Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol: 2013; 42 1 34 40
8. Gil M. M., Quezada M. S., Revello R., Akolekar R., Nicolaides K. H. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol: 2015; 45 3 249 266
9. Neufeld-Kaiser W. A., Cheng E. Y., Liu Y. J. Positive predictive value of non-invasive prenatal screening for fetal chromosome disorders using cell-free DNA in maternal serum: independent clinical experience of a tertiary referral center. BMC Med: 2015; 13 129
10. Mercer M. B., Agatisa P. K., Farrell R. M. What patients are reading about noninvasive prenatal testing: an evaluation of Internet content and implications for patient-centered care. Prenat Diagn: 2014; 34 10 986 993
11. Tiller G. E., Kershberg H. B., Goff J., Coffeen C., Liao W., Sehnert A. J. Women's views and the impact of noninvasive prenatal testing on procedures in a managed care setting. Prenat Diagn: 2015; 35 5 428 433
12. Hall S., Bobrow M., Marteau T. M. Psychological consequences for parents of false negative results on prenatal screening for Down's syndrome: retrospective interview study. BMJ: 2000; 320 (7232): 407 412
13. Wong A. E., Collingham J. P., Koszut S. P., Grobman W. A. Maternal factors associated with misperceptions of the second-trimester sonogram. Prenat Diagn: 2012; 32 11 1029 1034
14. Goel V., Glazier R., Holzapfel S., Pugh P., Summers A. Evaluating patient's knowledge of maternal serum screening. Prenat Diagn: 1996; 16 5 425 430
15. Cho R. N., Plunkett B. A., Wolf M. S., Simon C. E., Grobman W. A. Health literacy and patient understanding of screening tests for aneuploidy and neural tube defects. Prenat Diagn: 2007; 27 5 463 467
16. Gates E. A. Communicating risk in prenatal genetic testing. J Midwifery Womens Health: 2004; 49 3 220 227
17. United States Census Bureau Educational Attainment in the United States. 2014;. Available at: http://www.census.gov/hhes/socdemo/education/data. Accessed February 18, 2016
18. Vlemmix F., Warendorf J. K., Rosman A. N., et al. Decision aids to improve informed decision-making in pregnancy care: a systematic review. BJOG: 2013; 120 3 257 266